CDSCO Flags Besto-Cof Cough Syrup as Spurious, Raipur Drug Lab Claims Batch Not Made by Listed Firm

Published On 2025-10-25 10:55 GMT | Update On 2025-10-25 10:55 GMT

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a warning after the State Drug Testing Laboratory (SDTL) in Raipur, Chhattisgarh, flagged the widely sold 'Besto-Cof Dry Cough Formula' as potentially spurious. The batch details are currently under investigation, with the manufacturing and expiry dates unavailable.

According to the report, the manufacturer listed on the product label is under scrutiny, and the firm claiming to produce the drug has confirmed that the batch in question was not manufactured by them, strongly suggesting it is a spurious product. The product was identified during routine testing, and its sale and distribution pose a potential risk to consumers.

Besto-Cof Dry Cough Formula is a syrup used to relieve dry, hacking coughs and symptoms of the common cold and allergies. It is manufactured by Bestochem Formulations India Ltd. The medication combines a cough suppressant, an antihistamine, and a decongestant.

Also Read: Cough Syrup Deaths Case: Madhya Pradesh HC defers bail plea of paediatrician

In accordance with the Drug and Cosmetic Act, a drug shall be deemed to be spurious—

(a) if it is imported under a name which belongs to another drug; or

(b) if it is an imitation of, or a substitute for, another drug or resembles another drug in a manner likely to deceive or bears upon it or upon its label or container the name of another drug unless it is plainly and conspicuously marked so as to reveal its true character and its lack of identity with such other drug; or

(c) if the label or the container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist; or

(d) if it has been substituted wholly or in part by another drug or substance; or

(e) if it purports to be the product of a manufacturer of whom it is not truly a product

The term “Spurious Drug” has been defined under Section 17-B of the Drugs and Cosmetics Act, 1940

	Medicines Flagged as Spurious
1	Besto-Cof DRY COUGH FORMULA	NA	Manufacturing Date: N/A Expiry Date: N/A	Manufacturer Name: Under Investigation Manufactured By: Under Investigation	State lab	SDTL Raipur, Chhattisgarh	SEP-2025	NSQ Remark: The product is purported to be spurious, however, the same is subject to outcome of investigationFirm Reply: The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug.

Medicines Flagged as Spurious

S.No

Name of Product

Batch No

Manufacturing Dates

Manufacturer Details

Reporting Source

Reporting by Lab/State

Reporting Month & Year

Remarks

Besto-Cof DRY COUGH FORMULA

Manufacturing Date: N/A

Expiry Date: N/A

Manufacturer Name: Under Investigation Manufactured By: Under Investigation

State lab

SDTL Raipur, Chhattisgarh

SEP-2025

NSQ Remark: The product is purported to be spurious, however, the same is subject to outcome of investigationFirm Reply: The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug.

Also Read: After Cough Syrup Deaths, IPC Issues Toolkit to Curb DEG, EG Contamination in Liquid Formulations

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Susmita Roy

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

CDSCO Flags Besto-Cof Cough Syrup as Spurious, Raipur Drug Lab Claims Batch Not Made by Listed Firm

Similar News

Syngene International plans to add bioconjugation suite for end-to-end Antibody-Drug conjugates development

CDSCO Panel Rejects Troikaa Pharma's High-Strength Paracetamol Injection Citing Safety Concerns

Sun Pharma Gets CDSCO Panel Approval to Conduct Phase III Study of Oral Semaglutide

CDSCO Ends Emergency-Use Authorization of Baricitinib for COVID-19 Treatment

Merck gets USFDA priority review for 2 applications for Keytruda, Keytruda Qlex in combo with Padcev for bladder cancer

CDSCO Flags 112 Drug Batches Including Telmisartan, Pantoprazole, Cefixime, Glimepiride as Not of Standard Quality

Zydus bags Health Canada approval for Mesalamine suppositories for active ulcerative proctitis